“There are so many producers that deserve recognition for their continued commitment to advancing the dairy industry,” said Linda Tikofsky, DVM, Boehringer Ingelheim. “These producers are choosing to do the right thing for their cows and consumers by mitigating the use of antibiotics and striving to optimize animal welfare.”
Boehringer Ingelheim’s Producers for Progress recognition program celebrates dairy producers who demonstrate a strong commitment to animal well-being through judicious antibiotic use.
After careful consideration of more than 65 applicants by an expert panel of judges, the 2020 Producers for Progress program winners are as follows:
- Grand Prize: Paul Lippert, Grass Ridge Farm LLC, Pittsville, Wisconsin
- First Place: Daren Rubingh, Rubingh’s Dairyland, Ellsworth, Michigan
- Second Place: Hans Breitenmoser, Breitenmoser Family Farms, Merrill, Wisconsin
“The world is a fast-moving place. As dairy farmers, we need to look for ways to use fewer resources, produce more milk and ensure consumers are purchasing safe, socially-conscious dairy products,” said grand-prize recipient Paul Lippert.
As a herdsman and human resource manager at his family-owned dairy farm, Lippert is constantly looking for ways to enhance animal welfare and believes employees perform their best when they understand the reasons behind how and why they’re completing each task.
“We encourage employees to ask questions and provide feedback on a regular basis. We hold monthly meetings to discuss a variety of topics; one of which is goal-setting, and rewarding employees for meeting those goals,” said Lippert.
“Having interns the past four years has also pressed us to evaluate and improve our dairy’s procedures. One of these projects included setting up on-farm culturing of mastitis cases to improve treatment efficacy.”
First-place prize recipient Daren Rubingh notes that mastitis is one of the most common and costly diseases found on dairy operations. He takes a six-step approach to mastitis management, which includes several disease prevention measures and using antibiotics only when needed.
“I personally milk every day so I can keep a close eye on the equipment, the cows and their teat end health,” explained Rubingh. “If my cattle are not clean, comfortable and well-cared for, then I am not satisfied.”
Hans Breitenmoser, second-place prize recipient, concludes, “We are nothing without our dairy cattle and our consumers. We owe it to our consumers to make sure that we do our due diligence, and our main priority has to be the animals we’re responsible for. We do well by both the animals and the consumers when we use antibiotics judiciously.”
Judges for this year’s program included Sandra Godden, DVM, University of Minnesota; Patrick Gorden, DVM, Iowa State University; and Linda Tikofsky, DVM, Boehringer Ingelheim.
Producers for Progress celebrates those who help protect the future of the dairy industry. For more information on the program, please visit Producers4Progress.com.
Paul Lippert of Grass Ridge Farm LLC in Pittsville, Wisconsin, was chosen as the grand-prize recipient for Boehringer Ingelheim’s 2020 Producers for Progress recognition program.
Daren Rubingh, of Rubingh’s Dairyland in Ellsworth, Michigan, was chosen as the first-place prize recipient for Boehringer Ingelheim’s 2020 Producers for Progress recognition program.
Hans Breitenmoser of Breitenmoser Family Farms in Merrill, Wisconsin, was chosen as the second-place prize recipient for Boehringer Ingelheim’s 2020 Producers for Progress recognition program.
Images available upon request, contact Kenna Rathai.
Boehringer Ingelheim Animal Health
The lives of animals and humans are interconnected in deep and complex ways. We know that when animals are healthy, humans are healthier too. Across the globe, our 10,000 employees are dedicated to delivering value through innovation, thus enhancing the well-being of both.
Respect for animals, humans and the environment is at the heart of what we do. We develop solutions and provide services to protect animals from disease and pain. We support our customers in taking care of the health of their animals and protect our communities against life- and society- threatening diseases.
Boehringer Ingelheim Animal Health is the second largest animal health business in the world, with net sales of $4.5 billion (4 billion euros) in 2019 and presence in more than 150 countries.
Making new and better medicines for humans and animals is at the heart of what we do. Our mission is to create breakthrough therapies that change lives. Since its founding in 1885, Boehringer Ingelheim has been independent and family-owned. We have the freedom to pursue our long-term vision, looking ahead to identify the health challenges of the future and targeting those areas of need where we can do the most good.
As a world-leading, research-driven pharmaceutical company, more than 51,000 employees create value through innovation daily for our three business areas: Human Pharma, Animal Health, and Biopharmaceutical Contract Manufacturing.
In 2019, Boehringer Ingelheim achieved net sales of $21.3 billion (19 billion euros). Our significant investment of over $3.9 billion (3.5 billion euros) in R&D drives innovation, enabling the next generation of medicines that save lives and improve quality of life.
We realize more scientific opportunities by embracing the power of partnership and diversity of experts across the life-science community. By working together, we accelerate the delivery of the next medical breakthrough that will transform the lives of patients now, and in generations to come.
©2020 Boehringer Ingelheim Animal Health USA Inc., Duluth, GA. All Rights Reserved. US-BOV-0566-2020